4.5 Review

The influence of the telomere-telomerase system on diabetes mellitus and its vascular complications

Journal

EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 19, Issue 6, Pages 849-864

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1517/14728222.2015.1016500

Keywords

diabetes mellitus; diabetic vascular complication; oxidative stress; telomere-telomerase system

Funding

  1. National Natural Science Foundation of China [81370885]
  2. Youth Project of the Third Military Medical University [SWH2013QN02]
  3. postgraduate innovation fund of Chong Qing [CYB14097]

Ask authors/readers for more resources

Introduction: The telomere-telomerase system plays an important role in the pathogenesis and disease progression of diabetes mellitus as well as in its vascular complications. Recent studies suggest that telomere shortening and abnormal telomerase activity occur in patients with diabetes mellitus, and targeting the telomere-telomerase system has become a prospective treatment for diabetes mellitus and its vascular complications. This review highlights the significance of the telomere-telomerase system and supports its role as a possible therapeutic target for patients with diabetes mellitus and its vascular complications Areas covered: This review covers the advances in understanding the telomere-telomerase system over the last 30 years and its significance in diabetes mellitus. In addition, it provides knowledge regarding the significance of the telomere-telomerase system in diabetes mellitus and its vascular complications as well as its role and mechanisms in oxidative stress, cell therapy and antioxidant activity Expert opinion: The telomere-telomerase system may be a potential therapeutic target that can protect against DNA damage and apoptosis in patients with diabetes mellitus and its vascular complications. DNA damage and apoptosis are associated with oxidative stress and are involved in the dysfunction of pancreatic beta cells, insulin resistance, and its vascular complications. Abnormalities in the telomere-telomerase system may be associated with diabetes mellitus and its vascular complications. Therapies targeting telomere-telomerase system, telomerase reverse transcriptase transfection and alterative telomere lengthening must be identified before gene therapy can commence.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available